SHOULDER & ELBOW
Similar ROM and clinical scores between high & low-dose corticosteroid for shoulder stiffness
J Shoulder Elbow Surg. 2017 Feb;26(2):209-215151 patients with shoulder stiffness were randomized to an intraarticular injection of either 40mg or 20mg triamcinolone acetonide (TA). The purpose of this study was to evaluate if high-dose TA demonstrated a significantly greater post-injection range of motion compared to low-dose TA. Average follow-up length was 17.6 months in the 40mg group and 18.1 months in the 20mg group. Results demonstrated significant within-group increases in forward flexion, external rotation, and internal rotation in both groups, with no significant between-group differences. In patients with diabetes, no patient in either group experienced a significant increase in blood glucose, fructosamine, and glycated haemoglobin (HbA1c) after 6 or 12 weeks.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
